In vitro studies of the renin-angiotensin system in human adipose tissue/adipocytes and possible relationship to SARS-CoV-2: a scoping review

References

• Muñoz-Durango N, Fuentes CA, Castillo AE, et al. Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci. 2016;17(7):797.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, et al. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369(9568):1208–20.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Varagic J. The ANG-(1–7)/ace2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol. 2010;298(6):F1297.
   PubMed Web of Science ®Google Scholar
• Cassis LA. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep. 2008;10(2):93.
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Moustaid-Moussa N. The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol. 2012;47(4):379.
   PubMed Web of Science ®Google Scholar
• Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27(2):163–177.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Summary table of SARS cases by country, 1 November 2002-7 August 2003. Available from: https://www.who.int/csr/sars/country/en/country2003_08_15.pdf.
   Google Scholar
• Worldometer. Total deaths of novel coronavirus (2019-nCov). [cited 2021 Jul 30]. Available from: https://www.worldometers.info/coronavirus/coronavirus-death-toll/
   Google Scholar
• Ryan PM, Caplice NM. Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019? Obesity. 2020;28(7):1191.
   PubMed Web of Science ®Google Scholar
• Martínez-Colón GJ, Ratnasiri K, Chen H, et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med. 2022 Dec 7;14(674):eabm9151. DOI:10.1126/scitranslmed.abm9151.
   PubMed Web of Science ®Google Scholar
• Oudit GY, Penninger JM. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy. Curr Heart Fail Rep. 2011;8(3):176–183.
   PubMedGoogle Scholar
• Zhong J, Guo D, Chen CB, et al. Prevention of angiotensin II – mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension. 2011;57(2):314–322. DOI:10.1161/HYPERTENSIONAHA.110.164244
   PubMed Web of Science ®Google Scholar
• Arksey H, O’malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
   Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-Scr): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
   PubMed Web of Science ®Google Scholar
• Munn Z, Peters MD, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between the systematic or scoping review approach. BMC Med Res Methodol. 2018;18:1–7.
   PubMed Web of Science ®Google Scholar
• Lefebvre C, Glanville J, Briscoe S, et al. Chapter 4: searching for and selecting studies. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M Welch V, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane; 2021. Available from: www.training.cochrane.org/handbook
   Google Scholar
• Han T, Kang J, Li G, et al. Analysis of 2019-nCov receptor ACE2 expression in different tissues and its significance study. Ann Transl Med. 2020;8(17):1077.
   PubMed Web of Science ®Google Scholar
• Kerslake R, Hall M, Randeva H, et al. Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: potential implications beyond loss of smell as a COVID-19 symptom. Int J of Mol Med. 2020;46(3):949–956.
   PubMed Web of Science ®Google Scholar
• Li MY, Li L, Zhang Y, et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(02):23–29.
   PubMedGoogle Scholar
• Liu H, Xin J, Cai S, et al. Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor. Elife. 2021;10:e64188.
   PubMed Web of Science ®Google Scholar
• Kristem L, Recamonde-Mendoza M, Cigerza G, et al. Roux-en-Y Gastric bypass downregulates angiotensin-converting enzyme 2 (ACE2) gene expression in subcutaneous white adipose tissue: a putative protective mechanism against severe COVID-19. Obes Surg. 2021;31(6):2831–2834.
   PubMed Web of Science ®Google Scholar
• Li L, Spranger L, Soll D, et al. Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections? Metabolism. 2020;113:154401.
   PubMed Web of Science ®Google Scholar
• Favre G, Legueult K, Pradier C, et al. Visceral fat is associated to the severity of COVID-19. Metabolism. 2021;115:154440.
   PubMed Web of Science ®Google Scholar
• Couselo-Seijas M, Almengló C, Agra-Bermejo RM, et al. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: diabetes and obesity as possible enhancer. Eur J Clin Invest. 2021;51(5):e13463.
   PubMed Web of Science ®Google Scholar
• Desterke C, Griscelli F, Imeri J, et al. Molecular investigation of adequate sources of mesenchymal stem cells for cell therapy of COVID-19 associated organ failure. Stem Cells Transl Med. 2021;10(4):568–571.
   PubMed Web of Science ®Google Scholar
• de Ligt M, Hesselink M, Jorgensen J, et al. The angiotensin II type 1 receptor blocker valsartan in the battle against COVID-19. Obesity. 2021;29(9):1423–1426.
   PubMed Web of Science ®Google Scholar
• MacKay DL, Tesar PJ, Liang LN, et al. Characterizing medullary and human mesenchymal stem cell-derived adipocytes. J of Cell Physiol. 2006;207(3):722–728.
   PubMed Web of Science ®Google Scholar
• Fain JN, Nesbit AS, Sudlow FF, et al. Release in vitro of adipsin, vascular cell adhesion molecule 1, angiotensin 1-converting enzyme, and soluble tumor necrosis factor receptor 2 by human omental adipose tissue as well as by the nonfat cells and adipocytes. Metabolism. 2007;56(11):1583–1590.
   PubMed Web of Science ®Google Scholar
• Fain JN, Buehrer B, Bahouth SW, et al. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism. 2008;57(7):1005–1015.
   PubMed Web of Science ®Google Scholar
• Achard V, Boullu-Ciocca S, Desbriere R, et al. Renin receptor expression in human adipose tissue. Am J Physiol Regul Integr Cop Physiol. 2007;292:274–282.
   Web of Science ®Google Scholar
• Schling P. Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation. Horm Metab Res. 2002;34(11–12):709–715.
   PubMed Web of Science ®Google Scholar
• Sysoeva VY, Ageeva LV, Tyurin-Kuzmin PA, et al. Local angiotensin II promotes adipogenic differentiation of human adipose tissue mesenchymal stem cells through type 2 angiotensin receptor. Stem Cell Res. 2017;25:115–122.
   PubMed Web of Science ®Google Scholar
• Than A, Xu S, Li R, et al. Angiotensin type 2 receptor activation promotes browning of white adipose tissue and brown adipogenesis. Sigl Transduct Target Ther. 2017;2:17022.
   PubMed Web of Science ®Google Scholar
• Engeli S, Janke J, Gorzelniak K, et al. Regulation of the nitric oxide system in human adipose tissue. J Lipid Res. 2004;45(9):1640–1648.
   PubMed Web of Science ®Google Scholar
• Brücher R, Cifuentes M, Acuña MJ, et al. Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans. Obesity. 2007;15(7):1643–1646.
   PubMed Web of Science ®Google Scholar
• Janke J, Engeli S, Gorzelniak K, et al. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes. 2002;51(6):1699–1707. 10.2337/diabetes.51.6.1699.
   PubMed Web of Science ®Google Scholar
• Dünner N, Quezada C, Berndt FA, et al. Angiotensin II signaling in human preadipose cells: participation of ERK1,2-dependent modulation of Akt. PLoS ONE. 2013;8(10):e375440.
   Web of Science ®Google Scholar
• Fuentes P, Acuña MJ, Cifuentes M, et al. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J Endocrinol. 2010;206(1):75–83.
   PubMed Web of Science ®Google Scholar
• Janke J, Schupp M, Engeli S, et al. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. J Hypertens. 2006;24(9):1809–1816.
   PubMed Web of Science ®Google Scholar
• Ye ZW, Wu XM, Jiang JG. Expression changes of angiotensin II pathways and bioactive mediators during human preadipocytes-visceral differentiation. Metabolism. 2009;58(9):1288–1296.
   PubMed Web of Science ®Google Scholar
• Than A, Leow MK, Chen P. Control of adipogenesis by the autocrine interplays between angiotensin 1-7/mas receptor and angiotensin II/AT1 receptor signaling pathways. J Biol Chem. 2013;288(22):15520–15531.
   PubMed Web of Science ®Google Scholar
• Sarzani R, Marcucci P, Salvi F, et al. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes. 2008;32(2):259–267.
   Web of Science ®Google Scholar
• Song K, Wang Z, Li W, et al. In vitro culture, determination, and directed differentiation of adult adipose-derived stem cells towards cardiomyocyte-like cells induced by angiotensin II. Appl Biochem Biotechnol. 2013;170(2):459–470.
   PubMed Web of Science ®Google Scholar
• Gaafar T, Shawky S, Attia W, et al. The role of angiotensin II in cardiomyogenic differentiation of human adipose tissue-derived mesenchymal stem cells. Comp Clin Pathol. 2015;24:879–885.
   Google Scholar
• Goossens GH, Bizzarri A, Venteclef N, et al. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation. 2011;124(1):67–76.
   PubMed Web of Science ®Google Scholar
• Harte A, McTernan P, Chetty R, et al. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation. 2005;111:1954–1961.
   PubMed Web of Science ®Google Scholar
• Menikdiwela KR, Ramalingam L, Allen L, et al. Angiotensin II increases endoplasmic reticulum stress in adipose tissue and adipocytes. Sci Rep. 2019;9(1):8481.
   PubMedGoogle Scholar
• Skurk T, van Harmelen V, Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol. 2004;24(7):1199–1203.
   PubMed Web of Science ®Google Scholar
• Polonis K, Becari C, Chahal CA, et al. Chronic intermittent hypoxia triggers a senescence-like phenotype in human white preadipocytes. Sci Rep. 2020;10:6846.
   PubMed Web of Science ®Google Scholar
• Skurk T, Lee YM, Hauner H. Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension. 2001;37:1336–1340.
   PubMed Web of Science ®Google Scholar
• Skurk T, van Harmelen V, Blum WF, et al. Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res. 2005;13(6):969–973.
   PubMedGoogle Scholar
• Li Y, Zuo L, Zhu W, et al. Telmisartan attenuates the inflamed mesenteric adipose tissue in spontaneous colitis by mechanisms involving regulation of neurotensin/microRNA-155. Biochem Pharmacol. 2015;93(4):461–469.
   PubMed Web of Science ®Google Scholar
• Boccara F, Auclair M, Cohen A, et al. HIV protease inhibitors activate the adipocyte renin angiotensin system. Antivir Ther. 2009;15(3):363–375.
   Web of Science ®Google Scholar
• Blumensatt M, Fahlbusch P, Hilgers R, et al. Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a. Basic Res Cardiol. 2017;112(1):2.
   PubMed Web of Science ®Google Scholar
• Rasha F, Kahathuduwa C, Ramlingam L, et al. Combined effects of eicosapentaenoic acid and adipocyte renin-angiotensin system inhibition on breast cancer cell inflammation and migration. Cancers (Basel). 2020;12(1):220.
   PubMed Web of Science ®Google Scholar
• Rasha F, Ramalingam L, Menikdiwela K, et al. Renin angiotensin system inhibition attenuates adipocyte-breast cancer cell interactions. Exp Cell Res. 2020;394(1):112114.
   PubMed Web of Science ®Google Scholar
• de Oliveira M, De Sibio MT, Mathias LS, et al. Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture. Mol Cell Endocrinol. 2020;15(515):110917.
   Google Scholar
• Patel VB, Mori J, McLean BA, et al. ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity. Diabetes. 2016;65(1):85–95. DOI:10.2337/db15-0399
   PubMed Web of Science ®Google Scholar
• Pinheiro TDA, Barcala-Jorge AS, Andrade JM, et al. Obesity and malnutrition similarly alter the renin-angiotensin system and inflammation in mice and human adipose. J Nutr Biochem. 2017;48:74–82.
   PubMed Web of Science ®Google Scholar
• Serazin V, Dos Santos E, Morot M, et al. Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity. Endocrine. 2004;25(2):97–104.
   PubMed Web of Science ®Google Scholar
• Prat-Larquemin L, Oppert JM, Clément K, et al. Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients. Obes Res. 2004;12(3):556–561.
   PubMedGoogle Scholar
• Sarzani R, Bordicchia M, Marcucci P, et al. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue. J Hum Hypertens. 2010;24:213–219.
   PubMed Web of Science ®Google Scholar
• Park S, Lu KT, Liu X, et al. Allele-specific expression of angiotensinogen in human subcutaneous adipose tissue. Hypertension. 2013;62:41–47.
   PubMed Web of Science ®Google Scholar
• Gorzelniak K, Engeli S, Janke J, et al. Hormonal regulation of the human adipose-tissue-renin-angiotensin system: relationship to obesity and hypertension. J Hypertens. 2002;20(5):965–973.
   PubMed Web of Science ®Google Scholar
• Malinowski M, Deja MA, Golba KS, et al. Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. Eur J Cardiothorac Surg. 2008;33(2):225–231.
   PubMed Web of Science ®Google Scholar
• Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci, USA. 2003;100(24):14211–14216.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
   PubMed Web of Science ®Google Scholar
• Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infects Dis. 2020;71(15):896–897.
   PubMed Web of Science ®Google Scholar
• Engeli S, Böhnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45(3):356–362.
   PubMed Web of Science ®Google Scholar
• Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020;19:100283.
   Google Scholar
• Williams B, Zhang Y. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet. 2020;395(10238):1671–1673.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Ahmad S, Groban L. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels. Nat Rev Cardiol. 2020;17(6):378.
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Vardeny O, Michel T, et al. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):2441–2448.
   PubMed Web of Science ®Google Scholar
• Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15(4):277–287.
   PubMed Web of Science ®Google Scholar
• Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1):24–36.
   PubMed Web of Science ®Google Scholar
• Hanssen MJ, van der Lans AA, Brans B, et al. Short-term cold acclimation recruits brown adipose tissue in obese humans. Diabetes. 2016;65(5):1179–1189.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Sun L, Hu X, et al. Compromised browning plasticity of primary subcutaneous adipocytes derived from overweight Chinese adults. Diabetol Metab Syndr. 2020;12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249–1260.
   PubMed Web of Science ®Google Scholar
• Cai L, Johnstone BH, Cook TG, et al. IFATS collection: human adipose tissue‐derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells. 2009;27(1):230–237.
   PubMed Web of Science ®Google Scholar
• Bai X, Alt E. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun. 2010;401(3):321–326.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity. 2017;47(3):406–420.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Reviews Mol Cell Biol. 2008;9(5):367–377.
   PubMed Web of Science ®Google Scholar